Takemasa Matsumoto - Concepedia

Author

Takemasa Matsumoto

Also Known As

Masaki Fujita, Norihito Omote, Shunsuke Maeda, T Matsumoto, T. Matsumoto, TAKAHIDE MATSUHITO, M.D., Takao MATSUMOTO, Takashige Kuraki, Takemasa MATSUMOTO, Takemasa Matsumoto

Publications

777

Citations

H-Index

Concepts

All Affiliations

Fukuoka University Kyushu University Fukuoka University Hospital Showa University Keio University

About

Takemasa Matsumoto is an author at Fukuoka University specializing in medicine, pulmonary medicine, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	258
2	Epidemiology	3	3	42
3	Health Sciences	1	1	14
4	Public Health	1	1	13
5	Allergy	1	1	23

Takemasa Matsumoto

Publications

346

Citations

H-Index

Page 1

	Year	Citations
Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis Takanori Akagi, Takemasa Matsumoto, Taishi Harada, Respiratory Medicine Advanced Lung DiseasePhysiologyIdiopathic Pulmonary FibrosisVital CapacityPulmonary Physiology	2009	130
The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force Qingbo S. Wang, Ryuya Edahiro, Ho Namkoong, Nature Communications	2022	48
The clinical efficacy and safety of a fluoroquinolone-containing regimen for pulmonary MAC disease Masaki Fujita, Hiroshi Ouchi, Eiji Harada, Journal of Infection and Chemotherapy Antifibrotic TherapyAdvanced Lung DiseasePharmacologyPulmonary Mac DiseasePulmonary Pharmacology	2011	30
Impaired host defence against <i>Mycobacterium avium</i> in mice with chronic granulomatous disease Masaki Fujita, Eiji Harada, Takemasa Matsumoto, Clinical & Experimental Immunology Microbial PathogensNadph OxidaseImmunologyOxidative StressInflammation	2010	23
The clinical efficacy and safety of micafungin–itraconazole combination therapy in patients with pulmonary aspergilloma Masaki Fujita, Hiroshi Ouchi, Eiji Harada, Journal of Infection and Chemotherapy Antifungal AgentMicafungin–itraconazole Combination TherapyAntibioticsAntifungal AgentsMedicine	2012	19
Critical role of tumor necrosis factor receptor 1 in the pathogenesis of pulmonary emphysema in mice Masaki Fujita, Hiroshi Ouchi, Satoshi Ikemage, International Journal of COPD	2016	18
Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of the Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2019–2020: General view of the pathogens' antibacterial susceptibility Issei Tokimatsu, Tetsuya Matsumoto, Hiroki Tsukada, Journal of Infection and Chemotherapy Molecular Diagnostic TechniquesAntibioticsEmerging Infectious DiseasesSurveillance CommitteeMedicine	2023	17
Adenoid Cystic Carcinoma of the Lung with an <i>EGFR</i> Mutation Masaki Fujita, Takemasa Matsumoto, Ryosuke Hirano, Internal Medicine PathologyPleural EffusionTumor BiologyOncologySurgical Pathology	2016	14
Japan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan Ho Namkoong, Ryuya Edahiro, Koichi Fukunaga, Virus EpidemiologyGenetic EpidemiologyCovid-19 EpidemiologyGenome-wide Association StudiesCovid-19	2021	13
Chronic <em>Pseudomonas aeruginosa</em> infection-induced chronic bronchitis and emphysematous changes in CCSP-deficient mice Masaki Fujita, Takemasa Matsumoto, Ryosuke Hirano, International Journal of COPD	2016	12

Page 1